Amendment to Schedule 13D Filing for Edesa Biotech, Inc.

This filing is an amendment (Amendment No. 9) to a Schedule 13D, jointly filed by Pardeep Nijhawan Medicine Professional Corporation, The Digestive Health Clinic Inc., 1968160 Ontario Inc., The New Nijhawan Family Trust 2015, and Dr. Pardeep Nijhawan, regarding their holdings in Edesa Biotech, Inc. common shares. The amendment details transactions and ownership as of March 2, 2026. Dr. Pardeep Nijhawan, through various entities and trusts, holds an aggregate of 2,040,785 common shares, representing approximately 19.99% of the issuer's outstanding shares. This includes shares acquired through purchases and restricted stock units granted in lieu of salary and bonus. The filing also notes that Dr. Nijhawan's ownership is subject to a 19.99% beneficial ownership blocker for Series B-1 Preferred Shares. Pardeep Nijhawan Medicine Professional Corporation holds 1,133,676 common shares, approximately 11.9% of the total outstanding shares. Other entities hold smaller percentages. The reporting persons acquired these securities for investment purposes and reserve the right to further transactions.